FDA Inspection 998978 — Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon Group (Ningxia) Pharmaceutical Co., Ltd. on January 13, 2017 in Shizuishan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 13, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Shizuishan (China)